T. Rowe Price Associates
KNSA icon

T. Rowe Price Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History

T. Rowe Price Associates’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
2025
Q1 		$373K Buy
2024
Q4 		$299K Buy
2024
Q3 		$306K Buy
2024
Q2 		$222K Buy
2021
Q3 		– Sell
2021
Q2 		$184K Buy